Sanofi Pasteur India
- All
- News
-
Sanofi Gets Philippines Approval to Market Dengue Prevention Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, on Wednesday said the Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for the prevention of dengue in Asia.
-
Sanofi India Surges as Arm Gets Approval for First Anti-Dengue Vaccine
Sanofi India shares advanced nearly 5 per cent to hit intraday high of Rs 4,450 after the Mexican government approved the world's first anti-dengue vaccine developed by France-based Sanofi Pasteur which is an arm of the India-listed Sanofi India.
-
Hope For India As World's First Anti-Dengue Vaccine Approved
At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus.
-
Considering All Options Against CCI Order: GlaxoSmithKline
Slapped with a penalty of nearly Rs 61 crore by the Competition Commission of India (CCI), GlaxoSmithKline Pharmaceuticals said on Monday that it would review the order and consider all options, including filing an appeal.
-
20 more firms to come under retrospective tax law, say sources
The additional cases will generate revenue of Rs 25,000 crore, ministry officials said, excluding the Rs 20,000 crore the government hopes to recover from British telecom operator Vodafone group. Euro Pacific Security and Pan Asia have already paid the taxes as per the IT Department’s tax demand, ministry officials said.
-
Sanofi to supply swine flu vaccine to US
Sanofi Pasteur on Monday said it has received order from the US health department to supply antigen for 27.3 million doses of Influenza A HINI 2009 monovalent vaccine for swine flu.
-
Sanofi Gets Philippines Approval to Market Dengue Prevention Vaccine
Sanofi Pasteur, the vaccines division of Sanofi, on Wednesday said the Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for the prevention of dengue in Asia.
-
Sanofi India Surges as Arm Gets Approval for First Anti-Dengue Vaccine
Sanofi India shares advanced nearly 5 per cent to hit intraday high of Rs 4,450 after the Mexican government approved the world's first anti-dengue vaccine developed by France-based Sanofi Pasteur which is an arm of the India-listed Sanofi India.
-
Hope For India As World's First Anti-Dengue Vaccine Approved
At a time when India is struggling with rising number of dengue cases with each passing year, the Mexican government has approved the world's first anti-dengue vaccine which is designed to protect people in the 9-45 age group from nine to 45 years from all four subtypes of the virus.
-
Considering All Options Against CCI Order: GlaxoSmithKline
Slapped with a penalty of nearly Rs 61 crore by the Competition Commission of India (CCI), GlaxoSmithKline Pharmaceuticals said on Monday that it would review the order and consider all options, including filing an appeal.
-
20 more firms to come under retrospective tax law, say sources
The additional cases will generate revenue of Rs 25,000 crore, ministry officials said, excluding the Rs 20,000 crore the government hopes to recover from British telecom operator Vodafone group. Euro Pacific Security and Pan Asia have already paid the taxes as per the IT Department’s tax demand, ministry officials said.
-
Sanofi to supply swine flu vaccine to US
Sanofi Pasteur on Monday said it has received order from the US health department to supply antigen for 27.3 million doses of Influenza A HINI 2009 monovalent vaccine for swine flu.
